Alligator Bioscience AB (publ) (STO:ATORX)
Sweden · Delayed Price · Currency is SEK 0.0254
-0.0003 (-1.17%)
Sep 4, 2026, 1:12 PM CET
Alligator Bioscience AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -77.7 | -51.35 | -233.89 | -248.59 | -193.4 | -141.74 |
Depreciation & Amortization | 13.28 | 1.96 | 9.88 | 10.43 | 11.31 | 12.31 |
Other Amortization | - | - | 0.02 | 0.06 | 0.13 | 0.13 |
Asset Writedown & Restructuring Costs | -12.2 | -12.2 | 38.83 | - | 0.32 | -1.3 |
Stock-Based Compensation | - | - | 0.06 | 0.07 | 0.1 | 0 |
Other Operating Activities | -22.4 | -70.95 | 2.07 | 1 | -0.05 | - |
Change in Accounts Receivable | 0.77 | 1.76 | 4.95 | 13.27 | -5.86 | -13.59 |
Change in Other Net Operating Assets | -15.88 | -25.2 | -43.69 | 34.47 | 14.84 | 17.14 |
Operating Cash Flow | -114.15 | -155.99 | -221.78 | -189.29 | -172.61 | -127.03 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -1.46 | - | -2.46 | -0.44 | -0.05 |
Sale of Property, Plant & Equipment | - | 3.67 | - | - | - | - |
Investing Cash Flow | - | 2.21 | - | -2.46 | -0.44 | -0.05 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 17 | 193.79 | - | - | - |
Long-Term Debt Repaid | - | -125.66 | -8.29 | -9.75 | -7.91 | -6.97 |
Net Debt Issued (Repaid) | -22.67 | -108.66 | 185.51 | -9.75 | -7.91 | -6.97 |
Issuance of Common Stock | 134.9 | 307.43 | 49.44 | 195.54 | 0.38 | 342.67 |
Repurchase of Common Stock | - | - | - | - | -0.38 | - |
Other Financing Activities | -15.19 | -46.18 | -14.33 | -24.22 | 0.08 | -33.9 |
Financing Cash Flow | 97.04 | 152.59 | 220.62 | 161.56 | -7.83 | 301.8 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.17 | -0.92 | -0.65 | -1 | 0.03 | 0.06 |
Net Cash Flow | -17.28 | -2.11 | -1.81 | -31.19 | -180.84 | 174.78 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -114.15 | -157.45 | -221.78 | -191.74 | -173.05 | -127.08 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -16761.38% | -18765.91% | -384.21% | -323.61% | -480.67% | -953.54% |
Free Cash Flow Per Share | -0.36 | -5.72 | -302.04 | -427.53 | -784.49 | -1417.17 |
Levered Free Cash Flow | -114.32 | -96.11 | -149.97 | -100.16 | -98.69 | -74.03 |
Unlevered Free Cash Flow | -103.26 | -68.44 | -140.38 | -99.86 | -98.29 | -73.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 7.02 | 16.49 | 4.04 | 0.48 | 0.65 | 0.24 |
Change in Working Capital | -15.12 | -23.44 | -38.74 | 47.74 | 8.98 | 3.56 |